Gold prices tick higher on fresh US tariff threats, Fed rate cut hopes
Investing.com - Orthofix (NASDAQ: OFIX) reported second quarter EPS of $-0.36, $0.05 better than the analyst estimate of $-0.41. Revenue for the quarter came in at $203.12M versus the consensus estimate of $196.16M.
Guidance
Orthofix sees FY 2025 revenue of $808.00M-$816.00M versus the analyst consensus of $813.40M.
Orthofix’s stock price closed at $10.85. It is down -11.86% in the last 3 months and down -37.79% in the last 12 months.
Orthofix saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Orthofix’s stock price’s past reactions to earnings here.
According to InvestingPro, Orthofix’s Financial Health score is "good performance".
Check out Orthofix’s recent earnings performance, and Orthofix’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar